From mouse to man: or what have we learned about cytokine-based anti-inflammatory therapies?
Tracey
K J
KJ
North Shore University Hospital-New York University Medical School, The Picower Institute for Medical Research, Manhasset 11030, USA. ktracey@picower.edu
Abraham
E
E
D000818:Animals; D000906:Antibodies / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000378:metabolism / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006801:Humans; D007249:Inflammation / Q000378:metabolism / Q000517:prevention & control; D051379:Mice; D018805:Sepsis / Q000378:metabolism* / Q000401:mortality / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism*
D000906:Antibodies; D016207:Cytokines; D014409:Tumor Necrosis Factor-alpha